Patents by Inventor David Carl Hagen

David Carl Hagen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100317543
    Abstract: Cyanine dye compounds having a substituted methine moiety that are nucleic acid stains, particularly for fluorescent staining of RNA, including compounds having the formula where R1 is a C1-C6 alkyl, sulfoalkyl, carboxyalkyl or C1-C6 alkoxy; each R2 is independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, fused benzo, trifluoromethyl, amino, sulfo, carboxy and halogen, that is optionally further substituted; at least one of R3, R4, and R5 is an alkyl, aryl, heteroaryl, cyclic, or heterocyclic moiety that is optionally substituted by alkyl, amino, aminoalkyl, carboxy, nitro, or halogen; and the remaining R3, R4 or R5 are hydrogen; X is S, O, or Se; and D is a substituted or unsubstituted pyridinium, quinolinium or benzazolium moiety.
    Type: Application
    Filed: August 5, 2010
    Publication date: December 16, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Jason Alfred DALLWIG, David Carl HAGEN, Ching-Ying CHEUNG, Gerald Alan THOMAS, Stephen YUE
  • Patent number: 7776529
    Abstract: Cyanine dye compounds having a substituted methine moiety that are nucleic acid stains, particularly for fluorescent staining of RNA, including compounds having the formula where R1 is a C1-C6 alkyl, sulfoalkyl, carboxyalkyl or C1-C6 alkoxy; each R2 is independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy, fused benzo, trifluoromethyl, amino, sulfo, carboxy and halogen, that is optionally further substituted; at least one of R3, R4, and R5 is an alkyl, aryl, heteroaryl, cyclic, or heterocyclic moiety that is optionally substituted by alkyl, amino, aminoalkyl, carboxy, nitro, or halogen; and the remaining R3, R4 or R5 are hydrogen; X is S, O, or Se; and D is a substituted or unsubstituted pyridinium, quinolinium or benzazolium moiety.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: August 17, 2010
    Assignee: Life Technologies Corporation
    Inventors: Jason Alfred Dallwig, David Carl Hagen, Ching-Ying Cheung, Gerald Alan Thomas, Stephen Yue
  • Publication number: 20100120051
    Abstract: Cyanine dye compounds having a negatively charged substituent that are nucleic acid stains, particularly for fluorescent staining of DNA, including compounds having the formula wherein W forms one or two fused 5- or 6-membered aromatic rings, a has a value of 0 or 1, n has a value of 0, or 1, X is O, S, or Se, and D is a pyridinium, or quinolinium moiety, provided that the compound has at least one negatively charged substituent.
    Type: Application
    Filed: January 12, 2010
    Publication date: May 13, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Jason Alfred DALLWIG, David Carl Hagen, Shih-Jung Huang, Gerald Alan Thomas, Stephen Yue
  • Publication number: 20090047683
    Abstract: Cyanine dye compounds having a negatively charged substituent that are nucleic acid stains, particularly for fluorescent staining of DNA, including compounds having the formula wherein W forms one or two fused 5- or 6-membered aromatic rings, ? has a value of 0 or 1, n has a value of 0, or 1, X is O, S, or Se, and D is a pyridinium, or quinolinium moiety, provided that the compound has at least one negatively charged substituent.
    Type: Application
    Filed: September 29, 2008
    Publication date: February 19, 2009
    Applicant: INVITROGEN CORPORATION
    Inventors: Jason Alfred Dallwig, David Carl Hagen, Shih-Jung Huang, Gerald Alan Thomas, Stephen Yue
  • Patent number: 7446202
    Abstract: Cyanine dye compounds having a negatively charged substituent that are nucleic acid stains, particularly for fluorescent staining of DNA, including compounds having the formula wherein W forms one or two fused 5- or 6-membered aromatic rings, a has a value of 0 or 1, n has a value of 0, or 1, X is O, S, or Se, and D is a pyridinium, or quinolinium moiety, provided that the compound has at least one negatively charged substituent.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: November 4, 2008
    Assignee: Molecular Probes, Inc.
    Inventors: Jason Alfred Dallwig, David Carl Hagen, Shih-Jung Huang, Gerald Alan Thomas, Stephen Yue
  • Patent number: 7282339
    Abstract: The present invention provides ligand-detection reagents, ligand analogs and methods for determining the presence of a ligand in a sample. The ligand-detection reagent comprises a ligand-binding antibody and a ligand analog to form an antibody-ligand analog complex wherein the ligand analog is covalently bonded to a reporter molecule. This complex may additionally comprise a labeling protein non-covalently bonded to the antibody to form a ternary complex wherein the labeling protein comprises a monovalent antibody fragment or a non-antibody protein that is covalently bonded to a label moiety. The reporter molecule is either quenched by the ligand-binding antibody or by the label moiety of the labeling protein, depending on the reporter molecule and the ligand-binding antibody, wherein the amount of quenching is directly related to the amount of ligand present in the sample.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: October 16, 2007
    Assignee: Invitrogen Corporation
    Inventors: Joseph Beechem, Kyle Richard Gee, David Carl Hagen, Iain D Johnson, Hee-Chol Kang, Christina Pastula